FDA approves Hospira cancer drug

LAKE FOREST, Ill. — The Food and Drug Administration has approved a generic chemotherapy drug made by Hospira, the drug maker said.

Hospira announced the approval of gemcitabine injection in the 200-mg, 1-g and 2-g formulations and plans to launch the drug in September. The drug is a generic version of Eli Lilly's Gemzar.

Various versions of the drug had sales of $750 million in 2010, according to Hospira.